Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia

Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia

Abstract Background Primary progressive aphasia (PPA) is a clinical dementia syndrome. Impairments in language (speaking, reading, writing, and understanding) are the primary and persistent symptoms. These impairments progress insidiously and devastate communication confidence, participation, and qu...

Full description

Bibliographic Details
Main Authors: Angela C. Roberts, Alfred W. Rademaker, Elizabeth Ann Salley, Aimee Mooney, Darby Morhardt, Melanie Fried-Oken, Sandra Weintraub, Marsel Mesulam, Emily Rogalski
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Trials
Subjects:
Primary progressive aphasia
Dementia
Telehealth
Speech
Language
Communication
Online Access:https://doi.org/10.1186/s13063-022-06162-7

Internet

https://doi.org/10.1186/s13063-022-06162-7

Similar Items